Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

The Diverse Involvement of Cigarette Smoking in Pancreatic Cancer Development and Prognosis.

Tytuł:
The Diverse Involvement of Cigarette Smoking in Pancreatic Cancer Development and Prognosis.
Autorzy:
Weissman S; From the Department of Medicine, Hackensack University-Palisades Medical Center, North Bergen, NJ.
Takakura K; Division of Gastroenterology and Hepatology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan.
Eibl G; Department of Surgery, David Geffen School of Medicine, University of California at Los Angeles.
Pandol SJ; Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA.
Saruta M; Division of Gastroenterology and Hepatology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan.
Źródło:
Pancreas [Pancreas] 2020 May/Jun; Vol. 49 (5), pp. 612-620.
Typ publikacji:
Journal Article; Review
Język:
English
Imprint Name(s):
Publication: Hagerstown, MD : Lippincott Williams & Wilkins
Original Publication: [New York, N.Y.] : Raven Press, [c1986-
MeSH Terms:
Carcinoma, Pancreatic Ductal/*diagnosis
Cigar Smoking/*adverse effects
Cigarette Smoking/*adverse effects
Pancreatic Neoplasms/*diagnosis
Carcinogenesis/drug effects ; Carcinogenesis/genetics ; Carcinoma, Pancreatic Ductal/chemically induced ; Carcinoma, Pancreatic Ductal/genetics ; Humans ; Models, Biological ; Mutation ; Oncogenes/genetics ; Pancreatic Neoplasms/chemically induced ; Pancreatic Neoplasms/genetics ; Risk Factors
References:
Cancers (Basel). 2017 Apr 28;9(5):. (PMID: 28452926)
Int J Cancer. 2010 Nov 15;127(10):2412-9. (PMID: 20143395)
J Pathol. 1993 Apr;169(4):457-63. (PMID: 8501544)
World J Gastroenterol. 2010 Feb 14;16(6):673-82. (PMID: 20135714)
Front Physiol. 2013 Sep 12;4:246. (PMID: 24062691)
Langenbecks Arch Surg. 2008 Jul;393(4):535-45. (PMID: 18193270)
JAMA Oncol. 2015 Jul;1(4):476-85. (PMID: 26181258)
Pancreatology. 2010;10(1):54-9. (PMID: 20332662)
J Cancer Res Clin Oncol. 2005 Oct;131(10):639-48. (PMID: 16091975)
Nat Commun. 2017 Aug 14;8(1):242. (PMID: 28808255)
Pancreas. 2017 Apr;46(4):582-588. (PMID: 28099253)
Am J Clin Nutr. 2008 Apr;87(4):801-9. (PMID: 18400700)
Pancreas. 2018 Mar;47(3):314-320. (PMID: 29401167)
J Natl Cancer Inst. 1994 Oct 19;86(20):1510-6. (PMID: 7932805)
N Engl J Med. 2014 Sep 11;371(11):1039-49. (PMID: 25207767)
Cancer Epidemiol Biomarkers Prev. 2007 Sep;16(9):1894-7. (PMID: 17855711)
Cancer Res. 2003 May 15;63(10):2585-8. (PMID: 12750283)
Oncotarget. 2017 Aug 3;8(49):85378-85391. (PMID: 29156726)
Immunol Lett. 2011 Jul;138(1):71-8. (PMID: 21420434)
Cell. 2016 Jun 2;165(6):1401-1415. (PMID: 27180906)
J Surg Oncol. 1998 Mar;67(3):151-9. (PMID: 9530884)
Best Pract Res Clin Gastroenterol. 2006 Apr;20(2):197-209. (PMID: 16549324)
World J Gastroenterol. 2014 Aug 28;20(32):11182-98. (PMID: 25170203)
Dig Dis Sci. 1986 Oct;31(10):1014-20. (PMID: 3757717)
Clin Epidemiol. 2018 Jul 09;10:789-797. (PMID: 30022856)
Cancer Res. 2004 Apr 1;64(7):2634-8. (PMID: 15059921)
Tumour Biol. 2014 Jul;35(7):6633-40. (PMID: 24699995)
Carcinogenesis. 2015 Aug;36(8):925-35. (PMID: 25998847)
Cancer. 1980 Feb;45(3):534-40. (PMID: 6243510)
Nat Commun. 2019 Apr 23;10(1):1858. (PMID: 31015415)
Gastroenterology. 2007 Jul;133(1):72-9; quiz 309-10. (PMID: 17631133)
Pancreas. 2011 Aug;40(6):931-7. (PMID: 21747317)
Semin Cancer Biol. 2019 Feb;54:50-62. (PMID: 29079305)
Cancer Detect Prev. 1997;21(6):497-509. (PMID: 9398990)
Gastroenterology. 2013 Jun;144(6):1199-209.e4. (PMID: 23622129)
Pancreas. 2011 Mar;40(2):265-70. (PMID: 21404460)
Trends Biochem Sci. 2014 Feb;39(2):91-100. (PMID: 24388967)
Int J Cancer. 1996 Jul 3;67(1):63-71. (PMID: 8690527)
Int J Cancer. 2010 May 15;126(10):2394-403. (PMID: 19790196)
Int J Epidemiol. 2001 Jun;30(3):540-6. (PMID: 11416080)
HPB (Oxford). 2016 Mar;18(3):236-46. (PMID: 27017163)
Biochem Biophys Res Commun. 2019 Feb 19;509(4):925-930. (PMID: 30642632)
Hepatology. 2012 Feb;55(2):465-75. (PMID: 21953056)
Am J Surg. 2011 Aug;202(2):214-9. (PMID: 21376305)
Am J Clin Oncol. 2018 Mar;41(3):295-301. (PMID: 26808259)
J Clin Oncol. 2017 Jun 1;35(16):1822-1828. (PMID: 28358654)
J Epidemiol. 2005 Jun;15 Suppl 2:S113-9. (PMID: 16127222)
Pancreas. 2014 Jan;43(1):47-52. (PMID: 24177141)
Ann Surg. 2012 Mar;255(3):517-22. (PMID: 22301608)
Am J Gastroenterol. 2017 Sep;112(9):1366-1372. (PMID: 28762376)
Gastrointest Cancer Res. 2008 Jul;2(4 Suppl):S16-9. (PMID: 19343141)
Front Biosci. 2008 May 01;13:4426-50. (PMID: 18508521)
Carcinogenesis. 2012 Sep;33(9):1617-28. (PMID: 22623649)
IARC Sci Publ. 1991;(105):54-61. (PMID: 1855913)
Diab Vasc Dis Res. 2017 Jul;14(4):265-276. (PMID: 28393534)
Pancreas. 2006 Jul;33(1):53-62. (PMID: 16804413)
Gastroenterology. 2003 Oct;125(4):1188-202. (PMID: 14517801)
Pancreas. 2006 Nov;33(4):364-70. (PMID: 17079941)
MMWR Surveill Summ. 2008 Sep 5;57(8):1-33. (PMID: 18772853)
Toxicol Res (Camb). 2016 Mar 17;5(3):938-945. (PMID: 30090402)
Am J Physiol Heart Circ Physiol. 2000 Sep;279(3):H1172-8. (PMID: 10993781)
Br J Cancer. 2003 Aug 4;89(3):519-23. (PMID: 12888824)
Sci Rep. 2017 Aug 29;7(1):9572. (PMID: 28851896)
Front Physiol. 2014 Jan 16;4:416. (PMID: 24474940)
Carcinogenesis. 2001 Mar;22(3):473-9. (PMID: 11238189)
Am J Gastroenterol. 2006 Jan;101(1):148-59. (PMID: 16405548)
Ann Oncol. 2012 Jul;23(7):1880-8. (PMID: 22104574)
Nutr Cancer. 2016;68(2):201-7. (PMID: 26847707)
Pancreas. 1987;2(1):14-24. (PMID: 3554225)
BMC Cancer. 2016 Mar 12;16:212. (PMID: 26968702)
Eur J Cancer. 2018 Mar;92:20-32. (PMID: 29413686)
Methods Mol Biol. 2019;1882:287-297. (PMID: 30378063)
Clin Pharmacol Ther. 2011 Jul;90(1):164-8. (PMID: 21633341)
Nature. 2005 Jun 9;435(7043):834-8. (PMID: 15944708)
Am J Epidemiol. 2009 Aug 15;170(4):403-13. (PMID: 19561064)
J Natl Cancer Inst. 1986 Jan;76(1):49-60. (PMID: 3455742)
Pancreatology. 2012 Jul-Aug;12(4):344-9. (PMID: 22898636)
Int J Oncol. 2012 Jul;41(1):5-14. (PMID: 22446714)
J Clin Invest. 2013 Mar;123(3):1241-61. (PMID: 23426183)
J Natl Cancer Inst. 2000 Dec 6;92(23):1888-96. (PMID: 11106680)
Fam Cancer. 2009;8(2):109-17. (PMID: 18763055)
Oncology. 2017;93 Suppl 1:102-106. (PMID: 29258117)
Gut. 2019 May;68(5):882-892. (PMID: 29798841)
J Clin Gastroenterol. 2014 Oct;48(9):801-5. (PMID: 24153158)
Oncol Rep. 2018 Mar;39(3):1347-1355. (PMID: 29328490)
Alcohol Res. 2017;38(2):173-182. (PMID: 28988572)
J Surg Oncol. 1999 Jul;71(3):171-81. (PMID: 10404134)
Arch Intern Med. 1996 Oct 28;156(19):2255-60. (PMID: 8885826)
Curr Opin Immunol. 2013 Apr;25(2):200-5. (PMID: 23422836)
J Clin Oncol. 2006 Nov 1;24(31):5017-24. (PMID: 17075121)
Gastroenterology. 2008 Jan;134(1):95-101. (PMID: 18061176)
Gastroenterol Res Pract. 2016;2016:7682387. (PMID: 27073394)
Front Physiol. 2014 Feb 14;5:52. (PMID: 24592240)
Pancreatology. 2017 Sep - Oct;17(5):773-781. (PMID: 28734721)
Gut. 2005 Apr;54(4):510-4. (PMID: 15753536)
Ann Surg. 2004 May;239(5):678-85; discussion 685-7. (PMID: 15082972)
J Gastroenterol Hepatol. 2012 Mar;27 Suppl 2:127-34. (PMID: 22320930)
Biochem Biophys Res Commun. 2018 Dec 2;506(4):962-969. (PMID: 30401562)
Cancer Res. 1993 Jun 15;53(12):2758-61. (PMID: 8389244)
Comput Struct Biotechnol J. 2018 Oct 29;16:479-487. (PMID: 30455857)
Cancer Causes Control. 2009 Dec;20(10):1799-810. (PMID: 19562492)
Cureus. 2019 Jan 11;11(1):e3867. (PMID: 30899618)
Mutat Res. 2002 Jan 15;513(1-2):37-48. (PMID: 11719088)
Int J Cancer. 1990 Apr 15;45(4):685-6. (PMID: 2323846)
World J Gastroenterol. 2017 Sep 14;23(34):6287-6293. (PMID: 28974895)
Clin Cancer Res. 2009 Jul 15;15(14):4674-9. (PMID: 19584151)
Entry Date(s):
Date Created: 20200521 Date Completed: 20210517 Latest Revision: 20210517
Update Code:
20240105
PubMed Central ID:
PMC7249487
DOI:
10.1097/MPA.0000000000001550
PMID:
32433397
Czasopismo naukowe
Despite extensive research in the pathogenesis, early detection, and therapeutic approaches of pancreatic ductal adenocarcinoma (PDAC), it remains a devastating and incurable disease. As the global incidence and prevalence of PDAC continue to rise, there is a pressing need to place strong emphasis on its prevention. Although it is widely recognized that cigarette smoking, a potentially modifiable risk factor, has been linked to PDAC development, its contribution to prognosis is still uncertain. Moreover, the mechanistic pathways of PDAC progression secondary to smoking are various and lack a summative narration. Herein, we update and summarize the direct and indirect roles cigarette smoking plays on PDAC development, review literature to conclude the impact cigarette smoking has on prognosis, and postulate a comprehensive mechanism for cigarette smoking-induced PDAC.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies